Long-term darapladib use does not affect coronary plaque composition assessed using multimodality intravascular imaging modalities: a randomized-controlled study.

about

Long-term darapladib use does not affect coronary plaque composition assessed using multimodality intravascular imaging modalities: a randomized-controlled study.

Item

http://www.wikidata.org/entity/Q50031036

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Long-term darapladib use does ...... a randomized-controlled study.

@en

Long-term darapladib use does ...... a randomized-controlled study.

@nl

type

Item

label

Long-term darapladib use does ...... a randomized-controlled study.

@en

Long-term darapladib use does ...... a randomized-controlled study.

@nl

prefLabel

Long-term darapladib use does ...... a randomized-controlled study.

@en

Long-term darapladib use does ...... a randomized-controlled study.

@nl

P1476

Long-term darapladib use does ...... a randomized-controlled study.

@en

P2093

Abhiram Prasad

http://www.w3.org/2001/XMLSchema#string

Megha Prasad

http://www.w3.org/2001/XMLSchema#string

Rajiv Gulati

http://www.w3.org/2001/XMLSchema#string

Ryan Lennon

http://www.w3.org/2001/XMLSchema#string

Woong Gil Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review.

Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting.

Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation.

Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target.

Coronary endothelial dysfunction is associated with inflammation and vasa vasorum proliferation in patients with early atherosclerosis

Evaluation of coronary adventitial vasa vasorum using 3D optical coherence tomography--animal and human studies.

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque.

Lipoprotein-associated phospholipase A(2) : review of its role as a marker and a potential participant in coronary endothelial dysfunction.

Coronary endothelial dysfunction in patients with early coronary artery disease is associated with the increase in intravascular lipid core plaque

P304

104-113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MCA.0000000000000573

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lilach O. Lerman

Amir Lerman

P577

2017-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29135482

http://www.w3.org/2001/XMLSchema#string

P932

5796853

http://www.w3.org/2001/XMLSchema#string